These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 7044195

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Grass pollen-induced hay fever treated with a new steroid fluocortin butylester (FCB).
    Moesgaard Nielsen V, Vinther B, Illum P.
    Rhinology; 1983 Sep; 21(3):257-63. PubMed ID: 6356306
    [Abstract] [Full Text] [Related]

  • 3. Perennial rhinitis treated with a new steroid: fluocortin butylester (FCB).
    Moesgaard-Nielsen V, Vinther B, Illum P, Harvig H.
    Rhinology; 1986 Sep; 24(3):175-9. PubMed ID: 3534992
    [Abstract] [Full Text] [Related]

  • 4. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P, Fokkens W.
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.
    Durham SR, Riis B.
    Allergy; 2007 Aug; 62(8):954-7. PubMed ID: 17620075
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
    Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T, Braun W.
    Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
    [Abstract] [Full Text] [Related]

  • 9. Nasal provocative test in patients allergic to pollen.
    Wojdas A, Rapiejko P, Zielnik-Jurkiewicz B, Kantor I.
    Ann Agric Environ Med; 2005 May; 12(2):173-6. PubMed ID: 16457469
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
    Baroody FM, Shenaq D, DeTineo M, Wang J, Naclerio RM.
    J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097
    [Abstract] [Full Text] [Related]

  • 13. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M, Neukirch C, Grandsaigne M, Leçon-Malas V, Ravaud P, Dehoux M, Aubier M.
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [Abstract] [Full Text] [Related]

  • 14. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
    Berkowitz RB, McCafferty F, Lutz C, Bazelmans D, Godfrey P, Meeves S, Liao Y, Georges G.
    Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
    [Abstract] [Full Text] [Related]

  • 15. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge.
    Erin EM, Zacharasiewicz AS, Nicholson GC, Tan AJ, Higgins LA, Williams TJ, Murdoch RD, Durham SR, Barnes PJ, Hansel TT.
    Clin Exp Allergy; 2005 Dec; 35(12):1608-14. PubMed ID: 16393327
    [Abstract] [Full Text] [Related]

  • 16. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A, Andersson M, Leflein J, Lildholdt T, Mygind N.
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [Abstract] [Full Text] [Related]

  • 17. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
    Pullerits T, Lindén A, Malmhäll C, Lötvall J.
    Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nasal challenge with allergen leads to maxillary sinus inflammation.
    Baroody FM, Mucha SM, Detineo M, Naclerio RM.
    J Allergy Clin Immunol; 2008 May; 121(5):1126-1132.e7. PubMed ID: 18367240
    [Abstract] [Full Text] [Related]

  • 20. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis.
    Boot JD, de Kam ML, Mascelli MA, Miller B, van Wijk RG, de Groot H, Cohen AF, Diamant Z.
    Allergy; 2007 Apr; 62(4):378-84. PubMed ID: 17362248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.